Comparisons of AUCs of different diabetes prediction models.

<p>AUC, Area under the curve; All biomarker levels were sex-specific except for hsCRP;</p><p>CDP: Sex, Age, Waist circumference, fasting glucose, hypertension, dyslipidaemia, family history of diabetes, physical activity and smoking status.</p><p>TNF-α R2: tumor neurosis factor-alpha receptor 2; hsCRP, high sensitivity C-reactive protein; IL-6, Interleukin-6; A-FABP, adipocyte-fatty acid-binding protein.</p

Multivariate prediction of diabetes according to CDP and biomarker risk score.

<p>WC, waist circumference; FG, fasting glucose; HT, hypertension; TNF-α R2: tumor neurosis factor-alpha receptor 2.</p

Log-likelihood ratio tests comparing the change before and after addition of biomarkers.

<p>-2LL, -2log-likelihood; p-value (χ², df = 1);</p><p>All biomarker levels were sex specific (except for hsCRP).</p><p>CDP: Sex, Age, Waist circumference, fasting glucose, hypertension, dyslipidaemia, family history of diabetes, physical activity and smoking status.</p><p>TNF-α R2: tumor neurosis factor-alpha receptor 2; hsCRP, high sensitivity C-reactive protein; IL-6, Interleukin-6; A-FABP, adipocyte-fatty acid-binding protein.</p

Baseline clinical and biochemical characteristics of subjects with and without incident type 2 DM in 5.3 years.

<p>Mean ± SD, median (interquartile-range), or percentage as appropriate.</p>a<p>Physical activity: active if having moderate intensity exercise for at least 30 minutes in one month. ^bSex-adjusted; ^cAdjusted for hypertensive treatment; ^dLog transformed before analysis. ^eExcluded subjects on lipid treatment;</p><p>Central obesity: waist circumference ≥90 cm (M)/80 cm (F).</p><p>Hypertension: systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or on hypertensive treatment.</p><p>Dyslipidaemia: triglycerides ≥1.7 mmol/L, HDL cholesterol <1.0 mmol/L (M)/1.3 mmol/L (F), LDL cholesterol ≥3.4 mmol/L, or on lipid treatment.</p

Baseline characteristics of patients.

<p>Baseline characteristics of patients.</p

Association of baseline factors with incident fracture.

<p>Association of baseline factors with incident fracture.</p

Association of different types of androgen deprivation therapy with bone health.

<p>Association of different types of androgen deprivation therapy with bone health.</p

Kaplan Meier analysis of fracture-free survival among patients prescribed various types of ADT.

<p>Kaplan Meier analysis of fracture-free survival among patients prescribed various types of ADT.</p